Tech meltdown provides an opportunity for rotation into undervalued sectors.
This corrective action has me feeling optimistic about some new opportunities.
Aratana Therapeutics, Trevena and Sangamo Therapeutics were among the biotech stock movers in premarket trading on Thursday.
An update on two small-caps that reported earnings.
©1996-2017 TheStreet, Inc. All rights reserved.Action Alerts PLUS is a registered trademark of TheStreet, Inc.